UBS on Bed Bath & Beyond (BBBY): Was Recent Acquisition Motivated By Slowing Core Growth?
Tweet
Share
E-mailGet Alerts BBBY Hot Sheet
Price: $4.35 --0%
Rating Summary:
4 Buy, 17 Hold, 14 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
4 Buy, 17 Hold, 14 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS maintains a 'Neutral' on Bed Bath & Beyond (NASDAQ: BBBY) price target of $71.00 (from $73.00).
Analyst, Michael Lasser, thinks the recent acquisition of Cost Plus was indeed because the company is realizing slower growth. And, after a quick review of BBBY's Q1 results, the 3% same-store sale comparison was the smallest since the second quarter of 2009. Also of note, if you remove BBBY's $0.06 EPS tax benefit, the company would have misses the $0.84 consensus estimate. Lastly, Lasser points out the the company's gross margin declined at its steepest rate since '08 and the overall lack of traffic may affect the company/stock longer term. Therefore, Lasser cuts FY14 EPS estimate from $5.04 to $4.94.
For an analyst ratings summary and ratings history on Bed Bath & Beyond click here. For more ratings news on Bed Bath & Beyond click here.
Shares of Bed Bath & Beyond closed at $73.67 yesterday.
Analyst, Michael Lasser, thinks the recent acquisition of Cost Plus was indeed because the company is realizing slower growth. And, after a quick review of BBBY's Q1 results, the 3% same-store sale comparison was the smallest since the second quarter of 2009. Also of note, if you remove BBBY's $0.06 EPS tax benefit, the company would have misses the $0.84 consensus estimate. Lastly, Lasser points out the the company's gross margin declined at its steepest rate since '08 and the overall lack of traffic may affect the company/stock longer term. Therefore, Lasser cuts FY14 EPS estimate from $5.04 to $4.94.
For an analyst ratings summary and ratings history on Bed Bath & Beyond click here. For more ratings news on Bed Bath & Beyond click here.
Shares of Bed Bath & Beyond closed at $73.67 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- NetEase.com (NTES) PT Raised to $168 at Goldman Sachs
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
